Report Detail

Request for Sample of this report

Pharma & Healthcare Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4614318
    • |
  • 02 September, 2024
    • |
  • Global
    • |
  • 119 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Age-related macular degeneration (AMD) is a progressive eye disease that affects the macula, a part of the retina responsible for central vision. The cells in the macula become damaged and begin to die, causing vision loss as a person ages. The disease is typically categorized into two types: dry age-related macular degeneration (AMD) and wet age-related macular degeneration (AMD). Dry AMD is more common and involves the formation of small, yellow deposits in the macula, while wet AMD is less common and involves the growth of abnormal blood vessels beneath the macula. In dry AMD, treatment options include vitamin supplements and lifestyle changes to reduce risk factors. In wet AMD, treatment involves medications that are injected into the eye to stop the growth of abnormal blood vessels. This treatment is called abnormal endothelial growth factor (anti-VEGF) therapy, and it works by blocking the protein that stimulates the growth of abnormal blood vessels.

According to our (Global Info Research) latest study, the global Age-Related Macular Degeneration (AMD) Treatment Drugs market size was valued at US$ 10400 million in 2023 and is forecast to a readjusted size of USD 15260 million by 2030 with a CAGR of 5.6% during review period.
The age-related macular degeneration (AMD) market trends are shaping the growth of the market. For instance rise in the adoption of age-related macular degeneration drugs (AMD) among the geriatric population suffering from age-related macular degeneration (AMD) drives the growth of the age-related macular degeneration (AMD) market size. For instance, according to the 2022 factsheet of World Health Organization, by 2030, 1 in 6 people in the world is projected to be aged 60 years or over, indicating a potential increase in the age-related macular degeneration (AMD) market size.
This report is a detailed and comprehensive analysis for global Age-Related Macular Degeneration (AMD) Treatment Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Age-Related Macular Degeneration (AMD) Treatment Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
Global Age-Related Macular Degeneration (AMD) Treatment Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
Global Age-Related Macular Degeneration (AMD) Treatment Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
Global Age-Related Macular Degeneration (AMD) Treatment Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Age-Related Macular Degeneration (AMD) Treatment Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Age-Related Macular Degeneration (AMD) Treatment Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ionis Pharmaceuticals, Inc, Bausch Health Companies Inc, Regeneron Pharmaceuticals Inc, Biogen, Novartis AG, Sanofi S.A., Bayer AG, Coherus Biosciences Inc, F. Hoffmann-La Roche Ltd, Apellis Pharmaceuticals Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Age-Related Macular Degeneration (AMD) Treatment Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Aflibercept
Ranibizumab
Others
Market segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Major players covered
Ionis Pharmaceuticals, Inc
Bausch Health Companies Inc
Regeneron Pharmaceuticals Inc
Biogen
Novartis AG
Sanofi S.A.
Bayer AG
Coherus Biosciences Inc
F. Hoffmann-La Roche Ltd
Apellis Pharmaceuticals Inc
AbbVie
Pfizer Inc.
Amgen Inc.
Samsung Bioepis
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Age-Related Macular Degeneration (AMD) Treatment Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Age-Related Macular Degeneration (AMD) Treatment Drugs, with price, sales quantity, revenue, and global market share of Age-Related Macular Degeneration (AMD) Treatment Drugs from 2019 to 2024.
Chapter 3, the Age-Related Macular Degeneration (AMD) Treatment Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Age-Related Macular Degeneration (AMD) Treatment Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Age-Related Macular Degeneration (AMD) Treatment Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Age-Related Macular Degeneration (AMD) Treatment Drugs.
Chapter 14 and 15, to describe Age-Related Macular Degeneration (AMD) Treatment Drugs sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Age-Related Macular Degeneration (AMD) Treatment Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Aflibercept
    • 1.3.3 Ranibizumab
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Age-Related Macular Degeneration (AMD) Treatment Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital Pharmacy
    • 1.4.3 Retail Pharmacy
    • 1.4.4 Online Pharmacy
  • 1.5 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size & Forecast
    • 1.5.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity (2019-2030)
    • 1.5.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Ionis Pharmaceuticals, Inc
    • 2.1.1 Ionis Pharmaceuticals, Inc Details
    • 2.1.2 Ionis Pharmaceuticals, Inc Major Business
    • 2.1.3 Ionis Pharmaceuticals, Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product and Services
    • 2.1.4 Ionis Pharmaceuticals, Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Ionis Pharmaceuticals, Inc Recent Developments/Updates
  • 2.2 Bausch Health Companies Inc
    • 2.2.1 Bausch Health Companies Inc Details
    • 2.2.2 Bausch Health Companies Inc Major Business
    • 2.2.3 Bausch Health Companies Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product and Services
    • 2.2.4 Bausch Health Companies Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Bausch Health Companies Inc Recent Developments/Updates
  • 2.3 Regeneron Pharmaceuticals Inc
    • 2.3.1 Regeneron Pharmaceuticals Inc Details
    • 2.3.2 Regeneron Pharmaceuticals Inc Major Business
    • 2.3.3 Regeneron Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product and Services
    • 2.3.4 Regeneron Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Regeneron Pharmaceuticals Inc Recent Developments/Updates
  • 2.4 Biogen
    • 2.4.1 Biogen Details
    • 2.4.2 Biogen Major Business
    • 2.4.3 Biogen Age-Related Macular Degeneration (AMD) Treatment Drugs Product and Services
    • 2.4.4 Biogen Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Biogen Recent Developments/Updates
  • 2.5 Novartis AG
    • 2.5.1 Novartis AG Details
    • 2.5.2 Novartis AG Major Business
    • 2.5.3 Novartis AG Age-Related Macular Degeneration (AMD) Treatment Drugs Product and Services
    • 2.5.4 Novartis AG Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Novartis AG Recent Developments/Updates
  • 2.6 Sanofi S.A.
    • 2.6.1 Sanofi S.A. Details
    • 2.6.2 Sanofi S.A. Major Business
    • 2.6.3 Sanofi S.A. Age-Related Macular Degeneration (AMD) Treatment Drugs Product and Services
    • 2.6.4 Sanofi S.A. Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Sanofi S.A. Recent Developments/Updates
  • 2.7 Bayer AG
    • 2.7.1 Bayer AG Details
    • 2.7.2 Bayer AG Major Business
    • 2.7.3 Bayer AG Age-Related Macular Degeneration (AMD) Treatment Drugs Product and Services
    • 2.7.4 Bayer AG Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Bayer AG Recent Developments/Updates
  • 2.8 Coherus Biosciences Inc
    • 2.8.1 Coherus Biosciences Inc Details
    • 2.8.2 Coherus Biosciences Inc Major Business
    • 2.8.3 Coherus Biosciences Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product and Services
    • 2.8.4 Coherus Biosciences Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Coherus Biosciences Inc Recent Developments/Updates
  • 2.9 F. Hoffmann-La Roche Ltd
    • 2.9.1 F. Hoffmann-La Roche Ltd Details
    • 2.9.2 F. Hoffmann-La Roche Ltd Major Business
    • 2.9.3 F. Hoffmann-La Roche Ltd Age-Related Macular Degeneration (AMD) Treatment Drugs Product and Services
    • 2.9.4 F. Hoffmann-La Roche Ltd Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
  • 2.10 Apellis Pharmaceuticals Inc
    • 2.10.1 Apellis Pharmaceuticals Inc Details
    • 2.10.2 Apellis Pharmaceuticals Inc Major Business
    • 2.10.3 Apellis Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Product and Services
    • 2.10.4 Apellis Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Apellis Pharmaceuticals Inc Recent Developments/Updates
  • 2.11 AbbVie
    • 2.11.1 AbbVie Details
    • 2.11.2 AbbVie Major Business
    • 2.11.3 AbbVie Age-Related Macular Degeneration (AMD) Treatment Drugs Product and Services
    • 2.11.4 AbbVie Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 AbbVie Recent Developments/Updates
  • 2.12 Pfizer Inc.
    • 2.12.1 Pfizer Inc. Details
    • 2.12.2 Pfizer Inc. Major Business
    • 2.12.3 Pfizer Inc. Age-Related Macular Degeneration (AMD) Treatment Drugs Product and Services
    • 2.12.4 Pfizer Inc. Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Pfizer Inc. Recent Developments/Updates
  • 2.13 Amgen Inc.
    • 2.13.1 Amgen Inc. Details
    • 2.13.2 Amgen Inc. Major Business
    • 2.13.3 Amgen Inc. Age-Related Macular Degeneration (AMD) Treatment Drugs Product and Services
    • 2.13.4 Amgen Inc. Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Amgen Inc. Recent Developments/Updates
  • 2.14 Samsung Bioepis
    • 2.14.1 Samsung Bioepis Details
    • 2.14.2 Samsung Bioepis Major Business
    • 2.14.3 Samsung Bioepis Age-Related Macular Degeneration (AMD) Treatment Drugs Product and Services
    • 2.14.4 Samsung Bioepis Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Samsung Bioepis Recent Developments/Updates

3 Competitive Environment: Age-Related Macular Degeneration (AMD) Treatment Drugs by Manufacturer

  • 3.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue by Manufacturer (2019-2024)
  • 3.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Age-Related Macular Degeneration (AMD) Treatment Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Age-Related Macular Degeneration (AMD) Treatment Drugs Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Age-Related Macular Degeneration (AMD) Treatment Drugs Manufacturer Market Share in 2023
  • 3.5 Age-Related Macular Degeneration (AMD) Treatment Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Age-Related Macular Degeneration (AMD) Treatment Drugs Market: Region Footprint
    • 3.5.2 Age-Related Macular Degeneration (AMD) Treatment Drugs Market: Company Product Type Footprint
    • 3.5.3 Age-Related Macular Degeneration (AMD) Treatment Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Region
    • 4.1.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Consumption Value by Region (2019-2030)
    • 4.1.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Average Price by Region (2019-2030)
  • 4.2 North America Age-Related Macular Degeneration (AMD) Treatment Drugs Consumption Value (2019-2030)
  • 4.3 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Consumption Value (2019-2030)
  • 4.5 South America Age-Related Macular Degeneration (AMD) Treatment Drugs Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity by Type (2019-2030)
  • 5.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Consumption Value by Type (2019-2030)
  • 5.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity by Application (2019-2030)
  • 6.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Consumption Value by Application (2019-2030)
  • 6.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity by Type (2019-2030)
  • 7.2 North America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity by Application (2019-2030)
  • 7.3 North America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country
    • 7.3.1 North America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Age-Related Macular Degeneration (AMD) Treatment Drugs Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity by Type (2019-2030)
  • 8.2 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity by Application (2019-2030)
  • 8.3 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country
    • 8.3.1 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity by Type (2019-2030)
  • 10.2 South America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity by Application (2019-2030)
  • 10.3 South America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country
    • 10.3.1 South America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Age-Related Macular Degeneration (AMD) Treatment Drugs Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Age-Related Macular Degeneration (AMD) Treatment Drugs Market Drivers
  • 12.2 Age-Related Macular Degeneration (AMD) Treatment Drugs Market Restraints
  • 12.3 Age-Related Macular Degeneration (AMD) Treatment Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Age-Related Macular Degeneration (AMD) Treatment Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Age-Related Macular Degeneration (AMD) Treatment Drugs
  • 13.3 Age-Related Macular Degeneration (AMD) Treatment Drugs Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Age-Related Macular Degeneration (AMD) Treatment Drugs Typical Distributors
  • 14.3 Age-Related Macular Degeneration (AMD) Treatment Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Age-Related Macular Degeneration (AMD) Treatment Drugs. Industry analysis & Market Report on Age-Related Macular Degeneration (AMD) Treatment Drugs is a syndicated market report, published as Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Age-Related Macular Degeneration (AMD) Treatment Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,634.36
    		3,951.54
    		5,268.72
    		3,132.00
    		4,698.00
    		6,264.00
    		494,682.00
    		742,023.00
    		989,364.00
    		291,380.40
    		437,070.60
    		582,760.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo